ArticleCancer medicine2025

Differences in Tumor-Infiltrating Lymphocyte Counts in the Peritumoral Area in Patients Undergoing Hepatic Resection After Lenvatinib and Atezolizumab Plus Bevacizumab Therapy for Hepatocellular Carcinoma.

Katsuya Toshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.